Pneumonia recovery reprograms the alveolar macrophage pool.
Guillon A, Arafa EI, Barker KA, Belkina AC, Martin I, Shenoy AT, Wooten AK, Lyon De Ana C, Dai A, Labadorf A, Hernandez Escalante J, Dooms H, Blasco H, Traber KE, Jones MR, Quinton LJ, Mizgerd JP.
JCI Insight. 2020 Feb 27;5(4):e133042. doi: 10.1172/jci.insight.133042.
PMID:31990682
Recruitment and training of alveolar macrophages after pneumococcal pneumonia.
Arafa EI, Shenoy AT, Barker KA, Etesami NS, Martin IM, Lyon De Ana C, Na E, Odom CV, Goltry WN, Korkmaz FT, Wooten AK, Belkina AC, Guillon A, Forsberg EC, Jones MR, Quinton LJ, Mizgerd JP.
JCI Insight. 2022 Mar 8;7(5):e150239. doi: 10.1172/jci.insight.150239.
PMID:35133985
Type I Interferon Targets Alveolar Macrophages to Promote Bacterial Pneumonia after Viral Infection.
Palani S, Uddin MB, McKelvey M, Shao S, Wu W, Bao X, Sun J, Sun K.
Am J Respir Cell Mol Biol. 2025 Aug;73(2):264-274. doi: 10.1165/rcmb.2024-0552OC.
PMID:39879546
The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy.
Anderson R, Feldman C.
Int J Mol Sci. 2023 Jul 3;24(13):11038. doi: 10.3390/ijms241311038.
PMID:37446214
The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia.
Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJ, de Boer JD, Hoogendijk AJ, de Beer R, de Vos A, Belzer C, de Vos WM, van der Poll T, Wiersinga WJ.
Gut. 2016 Apr;65(4):575-83. doi: 10.1136/gutjnl-2015-309728. Epub 2015 Oct 28.
PMID:26511795
Interaction between alveolar macrophages and epithelial cells during Mycoplasma pneumoniae infection.